These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4552917)

  • 1. Combined chemoimmunostimulation therapy against murine leukemia.
    Pearson JW; Pearson GR; Gibson WT; Chermann JC; Chirigos MA
    Cancer Res; 1972 May; 32(5):904-7. PubMed ID: 4552917
    [No Abstract]   [Full Text] [Related]  

  • 2. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
    Chaparas SD; Chirigos M; Pearson J; Sher N
    Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined drug and immunostimulation therapy against a syngeneic murine leukemia.
    Pearson JW; Chirigos MA; Chaparas SD; Sher NA
    J Natl Cancer Inst; 1974 Feb; 52(2):463-8. PubMed ID: 4593139
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.
    Chirigos MA; Pearson JW; Pryor J
    Cancer Res; 1973 Nov; 33(11):2615-8. PubMed ID: 4795224
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of murine leukemia to combined BCNU-maleic anhydride-vinyl ether (MVE) adjuvant therapy and correlation with macrophage activation by MVE in the in vitro growth inhibition assay.
    Dean JH; Padarathsingh ML; Keys L
    Cancer Treat Rep; 1978 Nov; 62(11):1807-16. PubMed ID: 728898
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
    Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of chemotherapeutically induced remission of a syneneic murine leukemia by L-2,3,5,6-tetrahydro-6-phenylimidazo[2.1-BETA]thiazole hydrochloride.
    Chirigos MA; Fuhrman F; Pryor J
    Cancer Res; 1975 Apr; 35(4):927-31. PubMed ID: 1116150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia.
    Pearson JW; Chaparas SD; Chirigos MA
    Cancer Res; 1973 Aug; 33(8):1845-8. PubMed ID: 4720796
    [No Abstract]   [Full Text] [Related]  

  • 10. L2C leukemia: a model of human acute leukemia.
    Murphy SG; LoBuglio AF
    Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resistance of AKR mice to the oncogenic action of Moloney murine sarcoma virus].
    Tsysina EN; Irlin IS
    Biull Eksp Biol Med; 1971 Oct; 72(10):85-8. PubMed ID: 5126159
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of three strains of BCG against a murine leukemia after drug therapy.
    Sher NA; Pearson JW; Chaparas SD; Chirigos MA
    J Natl Cancer Inst; 1973 Dec; 51(6):2001-3. PubMed ID: 4587756
    [No Abstract]   [Full Text] [Related]  

  • 13. [In-vivo effectivity of heterologous rabbit antisera against mouse leukemias].
    Milleck J; Pasternak G
    Arch Geschwulstforsch; 1973; 42(3):192-7. PubMed ID: 4361626
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.
    Lemonde P
    Natl Cancer Inst Monogr; 1973 Dec; 39():21-32. PubMed ID: 4362522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of nitrosoalkylureas and the longevity of tumor-bearing animals].
    Krutova TV; Kondradov AA; Ostrovskaia LA
    Izv Akad Nauk SSSR Biol; 1983; (6):843-50. PubMed ID: 6655115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transformation in a rat fibroblast culture caused by the Moloney virus].
    Kukaĭn RA; Berzinia ME; Nagaeva LI; Nitavskaia SD
    Vopr Onkol; 1972; 18(4):63-6. PubMed ID: 4555015
    [No Abstract]   [Full Text] [Related]  

  • 17. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
    Bartlett GL; Purnell DM; Kreider JW
    Science; 1976 Jan; 191(4224):299-301. PubMed ID: 1108198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological analysis of N-nitrosourea-induced rat leukemia and experimental trials for therapy of human leukemia.
    Imamura N; Okada K
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1307-13. PubMed ID: 7168310
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of immune modulators on the oncogenic process: adjuvant effect of Staphylococcus aureus in treating murine leukemia.
    Chirigos MA; Theodore T
    Ann N Y Acad Sci; 1976; 276():513-9. PubMed ID: 1071976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.